US FDA Warns NJ Firm On Drug And Supplement GMPs, Indian Firm On Diethylene Glycol Testing

Agency’s latest posting of warning letters submitted also includes more warnings about OTC hand sanitizer production failing to meet GMP requirements.

• Source: Shutterstock

A US firm with drug and dietary supplement manufacturing quality control problems and an Indian firm inadequately testing for diethylene glycol in an ingredient typically used in toothpaste are among the consumer health businesses recently warned by US regulators.

The Food and Drug Administration’s latest posting of warning letters it has submitted also includes more warnings about OTC hand...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Compliance

More from Policy & Regulation